St. Petersburg, Russian Federation
May 4 - May 6, 2006
The aim of this symposium is to have an overview on the opportunities that the Healthcare professionals, working in the field of Reproductive Health, have to ensure the infertile couple to receive the most cost effective and safe treatments to have a healthy child one at a time.
The whole scientific community aspires to leverage Reproductive Health techniques in order to obtain safer procedures and improve the outcomes of ART. Under this light, the genetic approach to infertility seems to promise a golden future for those patients aspiring to a pregnancy. The main ongoing debates go through the implications of Pre-implantation Genetics Diagnosis, Genetic predisposition towards pharmaceuticals, Patient profile tailored protocols and their impact on ovarian stimulation.
The aim of this symposium is to have an overview on the opportunities that the Healthcare professionals, working in the field of Reproductive Health, have to ensure the best results in their ART procedures, while preventing or managing any factors that would impact their outcomes, such as those diseases strictly related to infertility.
LEARNING OBJECTIVES
After attending this symposium, the participants will have an updated knowledge on:
- Role of genetics and application of pharmacogenomics in reproductive health
- Use of PGD for infertility and PGD relevance for clinical practice
- Factors determining ovarian poor response and impact of LH or GH implementation
- Aspects determining ovarian high/over response
- Management of treatment side effects such as OHSS
TARGET AUDIENCE
Gynecologists, geneticists, clinicians, embryologists, biologists, paramedical staff and students working in the field of reproductive medicine.
Serono Symposia International Foundation (www.seronosymposia.org) has submitted this program “From genetics to patient tailored therapy - vision of the future” for accreditation by the European Accreditation Council for Continuing Medical Education (EACCME).